GZERO Media logo
{{ subpage.title }}

Do the global poor have a champion in the World Bank?

For the first time in twenty years, extreme poverty around the world is growing. How does the developing world recover from a pandemic that has brought even the richest nations to their knees? David Malpass, the President of the World Bank, is tasked with answering that question. He joins Ian Bremmer on GZERO World to talk about how his organization is trying to keep the developing world from slipping further into poverty in the wake of a once-in-a-century pandemic.

Podcast: Do the global poor have a champion in the World Bank?

Listen: For the first time in twenty years extreme poverty around the world is growing. How does the developing world recover from a pandemic that has brought even the richest nations to their knees? David Malpass, the President of the World Bank, is tasked with answering that question. He joins Ian Bremmer on the podcast to talk about how his organization is trying to keep the developing world from slipping further into poverty in the wake of a once-in-a-century pandemic.

What are the “known unknowns” about Moderna’s vaccine?

Moderna co-founder Noubar Afeyan concedes that there is plenty he still doesn't know about his company's COVID-19 vaccine, just as there's plenty he still doesn't know about the virus. But he is confident about one thing: "I view the vaccine as the best mask. It's a molecular mask, and once we have it onboard once, then presumably it will protect us." His conversation with Ian Bremmer was part of the latest episode of GZERO World.

Watch the GZERO World episode: A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine

Moderna’s co-founder Noubar Afeyan on the growing pushback against a COVID-19 vaccine

"In any debate, if one side has to offer facts and the other side can offer doubts and they're considered of equal value, then the ones who offer doubts will always have an advantage." Moderna co-founder Noubar Afeyan isn't naïve about the pushback that his company's COVID-19 vaccine will receive when it hits the US market. Disinformation around vaccine safety and efficacy was rampant even before the pandemic began. His conversation with Ian Bremmer was part of the latest episode of GZERO World.

Watch the GZERO World episode: A Shot in the Arm: Moderna’s Co-Founder on the COVID-19 Vaccine

Podcast: COVID Vaccine in Record Time - What Now? Moderna Co-Founder Noubar Afeyan

Listen: The pandemic's US death toll shows no signs of abating and the holiday season's spike will likely dwarf any surge that came before it. But in the midst of this dark winter there are glimmers of hope, as the first of the COVID-19 vaccines have nearly arrived (or, depending on when you read this, already have). On the GZERO World podcast, Ian Bremmer interviews Noubar Afeyan, the co-founder of a leading vaccine developer Moderna. They'll discuss distribution plans, the revolutionary science behind Moderna's vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.

Latest